These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 2497719

  • 1. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR.
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC, Julve J, Marzal-Casacuberta A, Ordóñez-Llanos J, González-Sastre F, Blanco-Vaca F.
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH, Alfarsi S, Adams PW.
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [Abstract] [Full Text] [Related]

  • 9. Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.
    Vargas-Vázquez A, Bello-Chavolla OY, Antonio-Villa NE, Mehta R, Cruz-Bautista I, Aguilar-Salinas CA.
    Lipids Health Dis; 2021 May 05; 20(1):46. PubMed ID: 33952259
    [Abstract] [Full Text] [Related]

  • 10. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.
    Clin Exp Hypertens; 2001 Aug 05; 23(6):489-500. PubMed ID: 11478431
    [Abstract] [Full Text] [Related]

  • 11. Increased arterial stiffness in familial combined hyperlipidemia.
    Brouwers MC, Reesink KD, van Greevenbroek MM, Meinders JM, van der Kallen CJ, Schaper N, Hoeks AP, Stehouwer CD.
    J Hypertens; 2009 May 05; 27(5):1009-16. PubMed ID: 19402225
    [Abstract] [Full Text] [Related]

  • 12. Concordant dyslipidemia, hypertension and early coronary disease in Utah families.
    Williams RR, Hunt SC, Wu LL, Hopkins PN, Hasstedt SJ, Schumacher MC, Stults BM, Kuida H.
    Klin Wochenschr; 1990 May 05; 68 Suppl 20():53-9. PubMed ID: 2189041
    [Abstract] [Full Text] [Related]

  • 13. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
    Kissebah AH, Alfarsi S, Evans DJ.
    Arteriosclerosis; 1984 May 05; 4(6):614-24. PubMed ID: 6508636
    [Abstract] [Full Text] [Related]

  • 14. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 15. Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study.
    Campos H, Wilson PW, Jiménez D, McNamara JR, Ordovas J, Schaefer EJ.
    Metabolism; 1990 Oct 15; 39(10):1033-8. PubMed ID: 2120547
    [Abstract] [Full Text] [Related]

  • 16. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
    Williams RR, Hunt SC, Hopkins PN, Wu LL, Hasstedt SJ, Berry TD, Barlow GK, Stults BM, Schumacher MC, Ludwig EH.
    Am J Hypertens; 1993 Nov 15; 6(11 Pt 2):319S-327S. PubMed ID: 8297539
    [Abstract] [Full Text] [Related]

  • 17. Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia.
    Verseyden C, Meijssen S, Cabezas MC.
    J Clin Endocrinol Metab; 2004 Oct 15; 89(10):5021-9. PubMed ID: 15472200
    [Abstract] [Full Text] [Related]

  • 18. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study.
    Kikuchi DA, Srinivasan SR, Harsha DW, Webber LS, Sellers TA, Berenson GS.
    Prev Med; 1992 Mar 15; 21(2):177-90. PubMed ID: 1579553
    [Abstract] [Full Text] [Related]

  • 19. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M, Berg A, Baumstark MW, König D, Huonker M, Keul Joseph.
    Atherosclerosis; 1999 Mar 15; 143(1):185-92. PubMed ID: 10208494
    [Abstract] [Full Text] [Related]

  • 20. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC, van Greevenbroek MM, Vermeulen VM, van Lin JM, van der Kallen CJ, de Bruin TW.
    Clin Sci (Lond); 2007 Nov 15; 113(9):375-81. PubMed ID: 17564583
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.